# DANTROLENE SODIUM
> **ANDA205239** · Abbreviated New Drug Application (Generic) · Sponsor: EUGIA PHARMA SPECLTS · Approved 2016-02-18
## Drug
- **FDA Application Number:** ANDA205239
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DANTROLENE SODIUM
- **Generic name:** Dantrolene Sodium
- **Active ingredients:** DANTROLENE SODIUM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** EUGIA PHARMA SPECLTS
- **First approval:** 2016-02-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205239)
---
*AI Analytics · CC0 1.0*